Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FX2EW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,559
Award facts
- Contract value 100% obligated
- $39,559.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $39,559.44 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. The contract, awarded on September 17, 2025, is a firm fixed-price delivery order with an ultimate completion date of October 8, 2025. This award was issued without a set-aside designation, allowing the vendor to compete on an unrestricted basis. DMS Pharmaceutical Group, registered in the System for Award Management since 2001, leverages its established position as a federal pharmaceutical supplier to fulfill this delivery requirement.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. The IDC encompasses a comprehensive portfolio of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide. Entyvio, a biologic medication used to treat inflammatory bowel conditions, represents one product category within the broader SPE2DB pharmaceutical supply program. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides direct distribution of prescription drugs and medical consumables to military health facilities across the United States and internationally.
Quick answers
Who was awarded contract SPE2DB25FX2EW?
SPE2DB25FX2EW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FX2EW worth?
The government has obligated $39,559 on SPE2DB25FX2EW.
Is contract SPE2DB25FX2EW an order under another contract?
Yes. SPE2DB25FX2EW is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2EW competed?
The extent of competition for SPE2DB25FX2EW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award